Frank Larsen

Title: Frank Larsen: Innovator in Pharmaceutical Compositions

Introduction

Frank Larsen is a notable inventor based in Valby, Denmark. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of synucleinopathies. With a total of four patents to his name, Larsen's work is focused on developing innovative solutions for complex medical conditions.

Latest Patents

Larsen's latest patents include compositions and methods for treating synucleinopathies. These inventions relate to stable and low viscosity liquid pharmaceutical compositions that comprise antibodies binding to human alpha synuclein. The methods outlined in his patents detail the use of these antibodies for treating synucleinopathies or prodromal synucleinopathy, including suitable doses and dosing regimens. The formulations are designed to enhance the effectiveness of treatments for these challenging conditions.

Career Highlights

Frank Larsen is currently associated with H. Lundbeck A/S, a company renowned for its focus on brain diseases. His work at Lundbeck has allowed him to contribute to groundbreaking research and development in the pharmaceutical industry. His expertise in creating effective treatments has positioned him as a key player in the field.

Collaborations

Larsen has collaborated with several talented individuals in his career, including Josefine Nielsen Søderberg and Pekka Kallunki. These collaborations have fostered a productive environment for innovation and have led to advancements in the treatment of neurological disorders.

Conclusion

Frank Larsen's contributions to the field of pharmaceuticals, particularly in the treatment of synucleinopathies, highlight his role as an influential inventor. His innovative patents and collaborations continue to pave the way for advancements in medical treatments.